Providing a strong foundation for life science entrepreneurs, the early stage venture ecosystem, and society at large.
The Genesis Consortium enables a greater range of VCs and corporates to invest more actively in the future of human and planetary health. We provide a strong foundation for life science entrepreneurs, the early stage venture ecosystem, and society at large.
We invite those committed to life science investing to join the Genesis Consortium alongside founding members SOSV’s IndieBio and Mayfield.
The Genesis Consortium works with IndieBio to produce regular in-person events on life sciences investing at IndieBio’s events spaces in San Francisco and New York City. In addition, the consortium participates in SOSV’s annual Climate Tech Summit.
SOSV’s IndieBio is the world’s first and leading startup development program for pre-seed founders working in bio-tech and life sciences. More than 200 companies have graduated from IndieBio since 2014, and they have gone on to raise $2.6 billion, including $163 million from SOSV, with an aggregate a valuation of $7.7 billion.
Mayfield is a global venture capital firm with $2.5 billion under management. The firm has been championing people for more than 50 years. Mayfield has $2.2 billion under management and has raised 20 funds, invested in more than 500 companies resulting in 117 IPOs and more than 200 mergers or acquisitions.
Get in Touch
If you want to be part of the Genesis Consortium or would like to get more info about what we’re building, please fill up the form and we’ll be in touch soon.